Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

GLP‐1 receptor agonists for Parkinson's disease

Esta versión no es la más reciente

ver la versión actual 23 julio 2020

Información

DOI:
https://doi.org/10.1002/14651858.CD012990Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 29 marzo 2018see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Trastornos del movimiento

Copyright:
  1. Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Caroline A Mulvaney

    Correspondencia a: Lancaster Medical School, Lancaster University, Lancaster, UK

    [email protected]

    [email protected]

  • Gonçalo S Duarte

    Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina de Lisboa, Lisboa, Portugal

    Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisboa, Portugal

  • Suresh Menon

    Department of Medicine, McMaster University, Hamilton, Canada

  • Joel Handley

    Lancaster Medical School, Lancaster University, Lancaster, UK

    Department of Neurology, Salford Royal Hospital, Salford, UK

  • Hedley C.A. Emsley

    Lancaster Medical School, Lancaster University, Lancaster, UK

    Department of Neurology, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK

Contributions of authors

The idea for the review was conceived by all authors. The protocol was drafted by all authors.

Sources of support

Internal sources

  • Internal sources of support, Other.

    No sources of support were received to write this protocol.

External sources

  • External sources of support, Other.

    No sources of support were received to write this protocol.

Declarations of interest

CAM: none known

GSD: none known

SM: none known

JH: none known

HCAE: none known

Acknowledgements

We thank Ema Roque, Managing Editor, Cochrane Movement Disorders Group for her help with this review. We thank Professor Christian Holscher for his help in writing this protocol.

Version history

Published

Title

Stage

Authors

Version

2020 Jul 23

GLP‐1 receptor agonists for Parkinson's disease

Review

Caroline A Mulvaney, Gonçalo S Duarte, Joel Handley, David JW Evans, Suresh Menon, Richard Wyse, Hedley CA Emsley

https://doi.org/10.1002/14651858.CD012990.pub2

2018 Mar 29

GLP‐1 receptor agonists for Parkinson's disease

Protocol

Caroline A Mulvaney, Gonçalo S Duarte, Suresh Menon, Joel Handley, Hedley C.A. Emsley

https://doi.org/10.1002/14651858.CD012990

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.